Overview

BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This study is to observe the long-term treatment of BG9924
Phase:
Phase 2
Details
Lead Sponsor:
Biogen
Treatments:
Methotrexate